Editorials

Human cells from cloned embryos in research and therapy

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7437.415 (Published 19 February 2004) Cite this as: BMJ 2004;328:415
  1. Ian Wilmut, head of department ([email protected])
  1. Department of Gene Expression and Development, Roslin Institute, Roslin, Midlothian EH25 9PS

    Current methods of cloning are repeatable but remain inefficient

    The recent report of the derivation of stem cells from a cloned human embryo takes a small, butsignificant, step towards revolutionary new opportunities in biology and medicine.1 By developing these techniques it will become possible to study human genetic diseases in entirely new ways, before in the longer term such cells may be used in the treatment of human disease. However, much remains to be learned about the techniques that are required before these opportunities can be realised. Furthermore, as with all new technical developments, experience will be needed to learn how such cells should best be used.

    The procedure that was used in the Korean experiment was essentially the same as that used to produce Dolly, the cloned sheep.2 During a series of trialsa total of 30 of the 242 cloned embryos developed normally for six days to reach the blastocyst stage before attempts were made to derive embryo stem cells.1 Cells were isolated from 20 of these embryos, and from these one stable cell line was derived. As would be expected of embryo stem cells, they had the ability to grow for a prolonged period in culture and to form other cell types. …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe